2015-2016年北京流感流行:甲型H3N2流感病毒循环与中等疫苗效果,与其他地区不同
该研究采用检测阴性设计评估2015-2016年北京三价灭活流感疫苗效果。纳入11000例合格患者,2969例(27.0%)流感阳性,疫苗接种率4.2%。调整后疫苗效果:所有流感8%(95%CI:-16%至27%),甲型H3N2为54%(95%CI:16%至74%),甲型H1N1pdm09为18%(95%CI:-38%至52%),乙型Victoria为-8%(95%CI:-40%至18%)。
要点
- 2015-2016年北京甲型H3N2疫苗效果为54%(95%CI:16%至74%)。
- 所有流感疫苗效果为8%(95%CI:-16%至27%),未达统计学显著。
- 仅接种当季疫苗效果-15%(95%CI:-63%至19%),两季均接种为18%(95%CI:-11%至40%)。
核心结论
- 2015-2016年三价灭活疫苗对北京流感感染总体有保护作用,对甲型H3N2的疫苗效果高于甲型H1N1pdm09和乙型流感病毒。
研究设计与样本
- 采用检测阴性研究设计,评估2015-2016年三价灭活疫苗对实验室确诊流感病毒感染的效果。
- 研究纳入11000例合格患者,其中2969例(27.0%)流感阳性。
- 同时分析既往接种对当季疫苗效果的影响。
主要发现
- 病例组和对照组的疫苗接种率均为4.2%。
- 调整后所有流感疫苗效果为8%(95%CI:-16%至27%)。
- 甲型H1N1pdm09疫苗效果为18%(95%CI:-38%至52%)。
- 甲型H3N2疫苗效果为54%(95%CI:16%至74%)。
- 乙型Victoria疫苗效果为-8%(95%CI:-40%至18%)。
关键数值与推荐
- 仅接种2015-2016年疫苗的总体疫苗效果为-15%(95%CI:-63%至19%)。
- 仅接种2014-2015年疫苗的总体疫苗效果为-25%(95%CI:-78%至13%)。
- 两个季节均接种疫苗的总体疫苗效果为18%(95%CI:-11%至40%)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: While the 2015-2016 influenza season in the northern hemisphere was dominated by A(H1N1)pdm09 and B/Victoria viruses, in Beijing, China, there was also significant circulation of influenza A(H3N2) virus. In this report we estimate vaccine effectiveness (VE) against influenza A(H3N2) and other circulating viruses, and describe further characteristics of the 2015-2016 influenza season in Beijing. METHODS: We estimated VE of the 2015-2016 trivalent inactivated vaccine (TIV) against laboratory-confirmed influenza virus infection using the test-negative study design. The effect of prior vaccination on current VE was also examined. RESULTS: Of 11,000 eligible patients included in the study, 2969 (27.0%) were influenza positive. Vaccination coverage was 4.2% in both cases and controls. Adjusted VE against all influenza was 8% (95% CI: -16% to 27%): 18% (95% CI: -38% to 52%) for influenza A(H1N1)pdm09, 54% (95% CI: 16% to 74%) for influenza A(H3N2), and -8% (95% CI: -40% to 18%) for influenza B/Victoria. The overall VE for receipt of 2015-2016 vaccination only, 2014-2015 vaccination only, and vaccinations in both seasons was -15% (95% CI: -63% to 19%), -25% (95% CI: -78% to 13%), and 18% (95% CI: -11% to 40%), respectively. CONCLUSIONS: Overall the 2015-2016 TIV was protective against influenza infection in Beijing, with higher VE against the A(H3N2) viruses compared to A(H1N1)pdm09 and B viruses.
引用
- Zhang L, Pan Y, Hackert V, et al. The 2015-2016 influenza epidemic in Beijing, China: Unlike elsewhere, circulation of influenza A(H3N2) with moderate vaccine effectiveness. Vaccine. 2018. PMID: 30017144. doi:10.1016/j.vaccine.2018.07.017
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。